双鹤药业（海南）有限责任公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
38
NMPA:38
Drug Approvals
Tigecycline for Injection
- Product Name
- 注射用替加环素
- Approval Number
- 国药准字H20253927
- Approval Date
- Apr 15, 2025
NMPA
Roxatidine Acetate Hydrochloride for Injection
- Product Name
- 注射用盐酸罗沙替丁醋酸酯
- Approval Number
- 国药准字H20244064
- Approval Date
- Jun 18, 2024
NMPA
Pantoprazole Sodium Enteric-Coated Capsules
- Product Name
- 泮托拉唑钠肠溶胶囊
- Approval Number
- 国药准字H20093903
- Approval Date
- Apr 2, 2024
NMPA
Pantoprazole Sodium Enteric-Coated Capsules
- Product Name
- 泮托拉唑钠肠溶胶囊
- Approval Number
- 国药准字H20123197
- Approval Date
- Mar 29, 2024
NMPA
Lansoprazole for Injection
- Product Name
- 注射用兰索拉唑
- Approval Number
- 国药准字H20140036
- Approval Date
- Feb 22, 2024
NMPA
Thymopentin for Injection
- Product Name
- 注射用胸腺五肽
- Approval Number
- 国药准字H20084025
- Approval Date
- Nov 28, 2022
NMPA
Clozapine orally disintegrating Tablets
- Product Name
- 氯氮平口崩片
- Approval Number
- 国药准字H20120081
- Approval Date
- May 10, 2022
NMPA
Pantoprazole Sodium for Injection
- Product Name
- 注射用泮托拉唑钠
- Approval Number
- 国药准字H20133321
- Approval Date
- Apr 17, 2021
NMPA
Pantoprazole Sodium for Injection
- Product Name
- 注射用泮托拉唑钠
- Approval Number
- 国药准字H20066256
- Approval Date
- Apr 17, 2021
NMPA
Rabeprazole Sodium Enteric-coated Tablets
- Product Name
- 雷贝拉唑钠肠溶片
- Approval Number
- 国药准字H20110160
- Approval Date
- Apr 2, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found